Clinical Trial Update: A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff Tear [Phase 2, Phase 3]

View source ↗

Summary

TPX-115 is being evaluated in a Phase 2b/3 study for partial-thickness rotator cuff tears, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotator Cuff Tear

Drugs mentioned

• TPX-115 (TPX-115)

Snippet

Sponsor: Tego Science, Inc. | Conditions: Partial Thickness Rotator Cuff Tear | Phase 2, Phase 3 | Status: RECRUITING